Menu
Back to Journals » Drug, Healthcare and Patient Safety » Volume 10
Corrigendum
Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial [Corrigendum]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,019 | Dovepress* | 4,811+ | 1,230 | 6,041 | |
| PubMed Central* | 208 | 105 | 313 | ||
| Totals | 5,019 | 1,335 | 6,354 | ||
| *Since 16 July 2018 | |||||
View citations on PubMed Central and Google Scholar